Hepatocellular Carcinoma (HCC) Clinical Trials near you me in Kansas City

HCC Current Trials

Age – Adult (18-85)
Gender – Female, Male

Disease Type – Hepatocellular carcinoma

Phase – 1b
Length – 60 months
Compensation available.


– Subjects with confirmed diagnosis of advanced or unresectable or recurrent solid tumor after treatment
– Adequately controlled blood pressure with or without antihypertensive medications
– Males and non-pregnant females
– HIV positive
– Meningeal carcinomatosis diagnosis
– Previously received E7386 treatment

Eisai: An Open-Label Phase 1b Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors

Learn More

Additional Information

For more information on what current clinical trials are available at Kansas City Research Institute or additional information and how to get involved, please contact our office phone at (816)759-2574 or send by email at study@kcresearchinstitute.com.

Contact Us